Nadine Gauchel

Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial

Axel Bauer, Michael Schreinlechner, Nikolay Sappler et al. · The Lancet Respiratory Medicine · 2021 · 105 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Barco, Davide Voci, Ulrike Held et al. · The Lancet Haematology · 2022 · 59 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19

Marina Rieder, Isabella Goller, Maren Jeserich et al. · Journal of Thrombosis and Thrombolysis · 2020 · 46 citations · Full text

Medicine, Clinical Sciences, Hematology +16

Peripheral serotonin lacks effects on endothelial adhesion molecule expression in acute inflammation

Maximilian Mauler, Nancy Schanze, Krystin Krauel et al. · Journal of Thrombosis and Haemostasis · 2021 · 15 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities

Marina Rieder, Nadine Gauchel, Klaus Kaier et al. · Clinical Research in Cardiology · 2021 · 13 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +13